ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 161 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2017. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $47,000 | +88.0% | 599 | +49.8% | 0.01% | +85.7% |
Q2 2019 | $25,000 | +150.0% | 400 | +100.0% | 0.01% | +250.0% |
Q1 2018 | $10,000 | -96.5% | 200 | -96.2% | 0.00% | -96.8% |
Q3 2017 | $282,000 | -30.2% | 5,300 | -18.5% | 0.06% | +5.1% |
Q2 2017 | $404,000 | -42.7% | 6,500 | -37.5% | 0.06% | -27.2% |
Q1 2017 | $705,000 | +169.1% | 10,400 | +181.1% | 0.08% | +138.2% |
Q3 2016 | $262,000 | -56.1% | 3,700 | -69.7% | 0.03% | -59.0% |
Q2 2016 | $597,000 | +108.7% | 12,200 | +378.2% | 0.08% | +130.6% |
Q4 2015 | $286,000 | -67.2% | 2,551 | -71.8% | 0.04% | -64.0% |
Q3 2015 | $872,000 | – | 9,051 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
First Light Asset Management, LLC | 217,459 | $24,760,000 | 1.64% |
Motley Fool Asset Management LLC | 152,326 | $17,344,000 | 1.25% |
Rock Springs Capital Management LP | 450,000 | $51,237,000 | 1.12% |
AtonRa Partners | 21,017 | $2,393,000 | 1.07% |
SECTORAL ASSET MANAGEMENT INC | 112,200 | $12,775,000 | 0.97% |
EMERALD ADVISERS, LLC | 228,368 | $26,002,000 | 0.94% |
EMERALD MUTUAL FUND ADVISERS TRUST | 239,023 | $27,215,000 | 0.90% |
FEDERATED HERMES, INC. | 3,912,408 | $445,467,000 | 0.86% |
HealthCor Management, L.P. | 207,610 | $23,638,000 | 0.84% |
Atika Capital Management LLC | 66,000 | $7,515,000 | 0.65% |